1.
Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.
2.
3.
4.
5.
Le medicament du mois. Rosuvastatine (Crestor). ; Drug of the month. Rosuvastatin (Crestor)
Risque de restenose et d'evenements cardiaques apres angioplastie coronaire chez le patient diabetique: reduction par des approches pharmacologiques systemiques. ; Incidence of res...